Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
City of Hope Medical Center
ClinicalTrials.gov Identifier:
NCT00478283
First received: May 23, 2007
Last updated: February 5, 2010
Last verified: February 2010

May 23, 2007
February 5, 2010
December 2006
October 2007   (final data collection date for primary outcome measure)
  • Attitudes and perspectives of health professionals [ Designated as safety issue: No ]
  • Homogeneity of treatment recommendations [ Designated as safety issue: No ]
  • Relative impact of chronological age, baseline health, and functional status on treatment recommendations [ Designated as safety issue: No ]
  • Attitudes and perspectives of health professionals
  • Homogeneity of treatment recommendations
  • Relative impact of chronological age, baseline health, and functional status on treatment recommendations
Complete list of historical versions of study NCT00478283 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer
Perspectives and Attitudes on the Use of Adjuvant Chemotherapy and Hormonal Therapy in Older and/or Frail Women: A Survey of Oncologists and Geriatricians

RATIONALE: A patient's age, health, and ability to perform daily activities may affect which treatment options are offered by doctors to older and/or frail women with breast cancer.

PURPOSE: This clinical trial is studying the views and attitudes of oncologists and geriatricians on the use of chemotherapy and hormone therapy in treating older and/or frail women with breast cancer.

OBJECTIVES:

  • Evaluate the attitudes and perspectives of 150 oncologists and 150 geriatricians or primary care providers regarding the adjuvant treatment of older women with breast cancer of varying ages, health, and functional status.
  • Determine whether homogeneity exists in treatment recommendations.
  • Determine the relative impact of chronological age, baseline health, and functional status on treatment recommendations.

OUTLINE: Participants complete a 25-minute online survey regarding their treatment recommendations for older women with breast cancer of varying ages, health, and functional status.

PROJECTED ACCRUAL: A total of 300 participants will be accrued for this study.

Interventional
Not Provided
Primary Purpose: Health Services Research
Breast Cancer
Other: survey administration
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
300
October 2007
October 2007   (final data collection date for primary outcome measure)

DISEASE CHARACTERISTICS:

  • Participants must meet 1 of the following criteria:

    • Oncologist:

      • Must have been in practice ≥ 2 years
      • Must have ≥ 25 postmenopausal breast cancer patients on adjuvant hormonal therapy
      • Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA
    • Geriatrician:

      • Must have been in practice ≥ 2 years
      • Must be a general practitioner, family practitioner, internal medicine specialist, or geriatrician and received a certificate of added qualification in geriatric medicine and/or treating at least 5 postmenopausal patients who have a history of breast cancer or are currently undergoing treatment for breast cancer
      • Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified
Both
Not Provided
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00478283
CDR0000540280, P30CA033572, CHNMC-06187
Not Provided
Arti Hurria MD, City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
Principal Investigator: Arti Hurria, MD Beckman Research Institute
City of Hope Medical Center
February 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP